Premature immunosenescence in rheumatoid arthritis.
Weyand
Cornelia M
CM
Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. weyand.cornelia@mayo.edu
Goronzy
Jörg J
JJ
D000222:Adaptation, Physiological; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D016922:Cellular Senescence / Q000276:immunology* / Q000502:physiology; D005260:Female; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects* / Q000379:methods; D008297:Male; D008875:Middle Aged; D008967:Molecular Biology; D011379:Prognosis; D018570:Risk Assessment; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology*
D018501:Antirheumatic Agents